Sri Lanka Clinical Trials Registry; and The Netherlands National Trial Register.
Search Strategy by Registry
ICTRP (http://apps.who.int/trialsearch/AdvSearch. aspx)
Condition: "Alzheimer" Result: 1174 records for 1048 trials found Condition: "Alzheimer" AND recruitment status: "Recruiting" ¶ Result: 379 records for 316 trials found. A manual review of all of them ended up with 46 'observational' studies: these are the first 46 included on Annex B.
¶ In the ICTRP, there are only two possibilities when conducting a search using Recruitment status as a descriptor: 'All' and 'recruiting'. 'All' includes all registered studies including those completed, early terminated, etc. This is why in the analysis 'recruiting' was chosen, to limit the search to studies that are active, and to prevent including those that are completed or terminated.
UK (ISCTRN) (http://www.isrctn.org/)
Keyword: Alzheimer Results: n = 39 Observational: n = 3 (one ISRCTN26135594 was retrieved through ICTRP and two new ones: ISRCTN49486383 and ISRCTN20278495)
The recruitment status of these studies is 'ongoing', which could mean that they are in the recruiting phase or that this phase has been completed and the participants are on the follow-up period. Following the information available, ISRCTN26135594 is on the recruitment phase. The investigating team of ISRCTN20278495 informed us that this study is on the recruitment phase.
ISRCTN20278495: This one had erroneous information regarding the number of participants. After contacting the investigating team, they acknowledged that the sample size (n = 10) on the registry was incorrect. The actual sample size is n = 300. This has been appropriately modified. In addition, data on NCT01425957 was also checked (see Germany). This study was registered as 'interventional' on ClinicalTrials.gov, whereas was correctly registered as 'non interventional' in the German registry (DRKS) *The descriptor 'closed' study includes all those observational studies that are Active, not recruiting, Completed, Terminated, Suspended, Withdrawn, Enrolling by invitation, or Unknown; whereas an 'open' study can be in two situations Recruiting or Not yet recruiting. 
USA (

Number of studies registered on ClinicalTrials.gov as of 9 June 2012
ANNEX B. CONFLICTING PERSPECTIVES ON 'OBSERVATIONAL' AND 'INTERVENTIONAL' STUDIES
In the analysis, the decision taken by the investigators/sponsors on whether their study is 'observational' or 'interventional' has been respected in all cases (except in those mentioned in the Results section of the manuscript and in Annex E), although from the methodological perspective a different opinion would have been appropriate. For instance, studies belonging to the clinical development of radiotracers as a diagnostic tool are always classified as 'interventional'. This has been considered and thus, not included in the analysis.
The WHO definition for clinical trial ("any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Clinical trials may also be referred to as interventional trials.") could support the concept that studies conducted for the development of radiotracers should not be considered as 'interventional', since these studies will not assess the effect of the radiotracer on the health of the participants. However, investigators and sponsors classify these studies as 'interventional', since they are considered as clinical trials by the Regulatory Agencies. Sponsors have to conduct a full clinical research development program to have the product granted by the Agencies. Strictly speaking from a methodological perspective (as opposed to the Regulatory perspective previously mentioned), studies with radiotracers should be considered as observational. This latter argument can be supported, not only using the WHO definition of interventional study or clinical trial, but also if the ClinicalTrials.gov definition is used: "Interventional studies are those in which the research subjects are assigned by the investigator to a treatment or other intervention, and their outcomes are measured".
ANNEX C. IDENTIFICATION OF STUDIES MENTIONED ON THE RESULTS SECTION OF THE ARTICLE
Articles' study IDs/Sentences as they appear in 'Results' Registry Study ID C1) Four studies that were considered as interventional NCT01314638; NCT01400542; NCT01251718; NCT01312363 C2) Primary end-point is to assess the changes of quality of life through medical treatment JPRN-UMIN000001256 C3) Brain biobank NCT00585572 C4) Repository of biospecimens and clinical data from neurological diseases to be used in future studies C16) The role of gene G72 in AD, Parkinson's disease and amyotrophic lateral sclerosis NCT01378026 C17) Assessment of the performance of a blood-based transcriptomic diagnostic test for AD NCT01465360 C18) Studies with transcriptomics and metabolomics NCT01315639; NCT01479855 C19) Study described as retrospective, although is actually prospective NCT00966017 C20) Study described as 'interventional' on ClinicalTrils.gov whereas on the German Clinical Trials Register is correctly described as 'observational' NCT01425957 C21) Study aim to follow each participant for 20 years NCT01421420 C22) A pilot study on whether preoperative CSF peptides concentrations would predict cognitive dysfunction 3 months after orthopedic surgery ACTRN12612000493842 C23) Study interviewing families caring for AD patients NCT01498263 C24) Screening for AD patients NCT00955422 C25) Study focused on health-related quality of life of patients NCT01570322 C26) Usefulness of psychometric tests to predict AD among subjects with subjective memory complaints NCT01316562 C27) Determination of the plasma concentration of pregnenolone sulphate as an early marker NCT00912886 C28) Prevalence of vitamin D deficiency in AD patients NCT01420315 C29) Assessment of the decision-making capacity of AD patients NCT01190800 C30) Assessment of pain perception of AD patients NCT00192816 C31) Study on assessing the blood brain barrier permeability NCT01574456 C32) Examination of serotoninergic transmission by PET NCT00192998 C33) The changes on the white matter by diffusion tensor image and MRI spectroscopy NCT00172900 C34) Evaluation of PET and SPECT imaging for optimal diagnosis NCT01231295; ISRCTN49486383 C35) Assessment of brain-specific deterioration on early and late onset AD, atypical AD and controls, by means of MRI, FDG-PET, A␤-PET, lumbar puncture and ApoE genotyping NCT01095744 C36) Multinational registry and cohort study being conducted to identify biomarkers in adult children of individuals with known mutation for AD (APP, PSEN1 or PSEN2).
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